Ads
related to: next gen sequencing companies- SLIMS for Pharma
Looking for a solution for Pharma?
Learn about SLIMS for Pharma labs.
- SLIMS for Biobanks
Looking for a solution for Biobank?
Learn more about SLIMS for Biobank.
- Request a Demo
Try SLIMS with your lab team.
Schedule a demo today.
- Applications
See the applications for SLIMS.
Pharma, Biobanks, NGS, and more.
- Features
Watch our comprehensive video on
features and capabilities of SLIMS.
- Contact Us
Have questions about SLIMS?
Contact us today.
- SLIMS for Pharma
Search results
Results From The WOW.Com Content Network
Massive parallel sequencing or massively parallel sequencing is any of several high-throughput approaches to DNA sequencing using the concept of massively parallel processing; it is also called next-generation sequencing (NGS) or second-generation sequencing.
BGI Group, formerly Beijing Genomics Institute, is a Chinese genomics company with headquarters in Yantian, Shenzhen. The company was originally formed in 1999 as a genetics research center to participate in the Human Genome Project. [3] [4] It also sequences the genomes of other animals, plants and microorganisms. [5]
In March 2013, Complete Genomics was acquired by BGI Group. [17] After the acquisition, Complete Genomics moved to San Jose, and in June 2018 became part of MGI. [18] [19] The acquisition was the one of the outcomes of $1.5 billion 'collaborative funds' i.e., '10 years loan' which was initially provided by China Development Bank to acquire all 128 of Illumina, Inc.'s newest and fastest next ...
The first of the high-throughput sequencing technologies, massively parallel signature sequencing (or MPSS, also called next generation sequencing), was developed in the 1990s at Lynx Therapeutics, a company founded in 1992 by Sydney Brenner and Sam Eletr. MPSS was a bead-based method that used a complex approach of adapter ligation followed by ...
The companies focus on using inflection points in medicine, such as deep learning, next-generation sequencing, and the silicon supply chain, to address global healthcare challenges. 4Catalyzer companies include Butterfly Network, Quantum-Si, Hyperfine, Tesseract Health, Liminal Sciences, Detect, AI Therapeutics, and Protein Evolution, Inc. [16]
Clear Labs, Inc. is a private genomics testing company headquartered in San Carlos, California, United States.It offers a fully automated, next-generation sequencing (NGS) platform for turnkey diagnostics, including SARS-CoV-2 genomic characterization and detection of foodborne pathogens such as listeria and salmonella. [1]
Ads
related to: next gen sequencing companies9.0/10 (380 reviews)